Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-022537)

Filing Details

Accession Number:: 0001209191-15-022537
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-04 18:52:50
Reporting Period:: 2015-03-02

Filing Date:: 2015-03-04
Accepted Time:: 2015-03-04 18:52:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
818033	Heron Therapeutics Inc.	HRTX	Pharmaceutical Preparations (2834)	942875566

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1384243	D Barry Quart	123 Saginaw Drive Redwood City CA 94063	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-02	10,000	$13.07	42,868	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of December 23, 2014.
The range of sales prices received was $12.94 to $13.43. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.